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Pain constitutes one of the most prevalent diagnoses in primary care settings (1), and is the complaint presented by nearly two-thirds of 
emergency department patients treated in the United States (US) (2). 
Estimates of the prevalence of all chronic pain in the US population range 
considerably, from 8% to 48%, depending on the stringency of the defin-
itions used. One recent review offered a weighted estimate of 22% (3); a 
somewhat more dated review provided an estimate of 15% (4). Opioid 
analgesics are the mainstay for pharmacological treatment for moderate to 
severe pain and have improved the quality of life for many (5-7). 
However, in the first decade of the 21st century, the amount of prescrip-
tion analgesics, such as fentanyl, hydrocodone, methadone, oxymorphone 
and oxycodone, increased by a factor of four (8), and deaths due to the 
abuse and misuse of such analgesics nearly doubled (9). In 2009, poisoning 
deaths became the leading cause of injury-related death in the US (10).
The recent advent of the Food and Drug Administration’s Risk 
Evaluation and Mitigation Strategies for extended-release and 
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BACkgRouND: Despite >20 years of studies investigating the charac-
teristics of patients seeking or receiving opioid analgesics, research charac-
terizing factors associated with physicians’ opioid prescribing practices has 
been inconclusive, and the role of practitioner specialty in opioid prescrib-
ing practices remains largely unknown.
oBjECTIvE: To examine the relationships between physicians’ and 
other providers’ primary specialties and their opioid prescribing practices 
among patients with chronic noncancer pain (CNCP).
METHoDS: Prescriptions for opioids filled by 81,459 Medicaid patients 
with CNCP in North Carolina (USA), 18 to 64 years of age, enrolled at 
any point during a one-year study period were examined. χ2 statistics were 
used to examine bivariate differences in prescribing practices according to 
specialty. For multivariable analyses, maximum-likelihood logistic regres-
sion models were used to examine the effect of specialty on prescribing 
practices, controlling for patients’ pain diagnoses and demographic charac-
teristics.
RESuLTS: Of prescriptions filled by patients with CNCP, who consti-
tuted 6.4% of the total sample of 1.28 million individuals, 12.0% were 
for opioids. General practitioner/family medicine specialists and internists 
were least likely to prescribe opioids, and orthopedists were most likely. 
Across specialties, men were more likely to receive opioids than women, as 
were white individuals relative to other races/ethnicities. In multivariate 
analyses, all specialties except internal medicine had higher odds of pre-
scribing an opioid than general practitioners: orthopedists, OR 7.1 (95% 
CI 6.7 to 7.5); dentists, OR 3.5 (95% CI 3.3 to 3.6); and emergency medi-
cine physicians, OR 2.7 (95% CI 2.6 to 2.8). 
CoNCLuSIoNS: Significant differences in opioid prescribing practices 
across prescriber specialties may be reflective of differing norms concerning 
the appropriateness of opioids for the control of chronic pain. If so, sharing 
these norms across specialties may improve the care of patients with 
CNCP. 
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Prescribing patterns
La prescription différentielle d’analgésiques 
opioïdes en fonction de la spécialité des médecins 
aux patients sur Medicaid atteints de douleurs 
non cancéreuses chroniques diagnostiquées
HISToRIQuE : Même si pendant plus de 20 ans, des études ont porté sur les 
caractéristiques des patients demandant ou recevant des analgésiques opioïdes, 
les données caractérisant les facteurs associés aux pratiques de prescription 
d’opioïdes par les médecins ne sont pas concluantes, et on ne sait pas grand-
chose du rôle de la spécialité du praticien dans les pratiques de prescription.
oBjECTIF : Examiner la relation entre les principales spécialités des 
médecins et des autres dispensateurs et leurs pratiques de prescription 
d’opioïdes auprès des patients atteints de douleurs non cancéreuses chro-
niques (DNCC).
MÉTHoDoLogIE : Les chercheurs ont examiné les prescriptions 
d’opioïdes remplies par 81 459 patients souffrant de DNCC de 18 à 64 ans sur 
Medicaid habitant en Caroline du Nord (États-Unis), inscrits à un moment 
ou à un autre pendant une étude d’un an. Ils ont examiné les statistiques χ2 
pour examiner les différences bivariées des pratiques de prescription en fonc-
tion de la spécialité. Dans les analyses multivariables, ils ont utilisé les 
modèles de régression logistique à pertinence maximale pour examiner l’effet 
de la spécialité sur les pratiques de prescription, le contrôle des diagnostics de 
douleur des patients et les caractéristiques démographiques.
RÉSuLTATS : Parmi les prescriptions remplies par les patients ayant des 
DNCC, qui représentaient 6,4 % de l’échantillon total de 1,28 million de 
personnes, 12,0 % l’étaient pour des opioïdes. Les omnipraticiens ou spé-
cialistes en médecine familiale et les internes étaient les moins susceptibles de 
prescrire des opioïdes, et les orthopédistes l’étaient le moins. Au sein des spé-
cialités, les hommes étaient plus susceptibles de recevoir des opioïdes que les 
femmes, et les personnes de race blanche davantage que celles des autres races 
ou ethnies. Dans les analyses multivariées, toutes les spécialités, sauf la méde-
cine interne, étaient plus susceptibles de prescrire un opioïde que les 
praticiens généraux : orthopédistes, RC 7,1 (95 % IC 6,7 à 7,5); dentistes, 
RC 3,5 (95 % IC 3,3 à 3,6); et médecins d’urgence, RC 2,7 (95 % IC 2,6 à 2,8). 
CoNCLuSIoNS : Les différences significatives des pratiques de prescription 
d’opioïdes en fonction des spécialités des prescripteurs reflètent peut-être des 
normes différentes quant à la pertinence des opioïdes pour contrôler la douleur 
chronique. Dans l’affirmative, il serait bon de partager ces normes dans toutes 
les spécialités pour améliorer les soins aux patients ayant des DNCC.
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long-acting opioid analgesics attempts to introduce consistency into 
prescribing behaviours (6) and to reduce the potential for harm among 
patients at risk for addiction or misuse. However, the Risk Evaluation 
and Mitigation Strategies provide little guidance regarding conditions, 
doses and opioid medication types because the regulation of medical 
practice is left to the states and cannot be regulated by the Food and 
Drug Administration. The American Society of Interventional Pain 
Physicians, the American Pain Society and the National Opioid Use 
Guideline Group of Canada have all developed guidelines to assist 
physicians in the management of opioids in chronic noncancer pain 
(CNCP); however, these serve as process management strategies 
rather than specific prescribing guidelines (11-13). The definition of 
what constitutes ‘adequate’ pain treatment remains unclear, and no 
particular treatment regimen has been endorsed by any single medical 
organization (14-16).
Despite more than two decades’ worth of studies of the characteris-
tics of patients seeking or receiving opioid analgesics, research charac-
terizing factors associated with physicians’ opioid prescribing practices 
has been inconclusive. For example, while some investigations have 
linked such prescriptions to pain scores (17), others have not (18,19), 
and have suggested instead that patients’ pain-related behaviours – 
particularly the level of distress and disability they manifest – may be 
more closely associated with prescribing practices than their scores. 
The role of practitioner specialty in opioid prescribing practices 
remains largely unknown, with conflicting results across studies 
(14,20). A recent study involving two million enrollees in a national 
health care plan revealed that specialists were more likely than non-
specialists (19.1% versus 13.7%) to prescribe an extended-release 
opioid for episodes of pain lasting at least 60 days (7). In contrast, a 
study involving almost 7000 physicians found that rheumatologists 
and general practitioners were more likely to prescribe long-term opi-
oids than surgeons, neurologists and psychiatrists (21). In a nationally 
representative sample of 121 million patients that included prescrip-
tion data from more than one-half of the nation’s retail pharmacies, 
Volkow et al (22) reported that primary care physicians (ie, general 
practitioners [GPs], and family medicine providers [FMs] and primary 
care internists) were the most likely providers (28.8%) to prescribe 
opioids, relative to internists (14.6%), dentists (8.0%) and orthopedic 
surgeons (7.7%). Furthermore, a study involving physicians who faced 
criminal prosecution or charges by medical boards for inappropriate 
opioid prescribing practices between 1998 and 2006 found that 39% 
were either general practitioners or family physicians, relative to 4% 
who were either self-identified or board certified as pain specialists 
(23). The lack of conclusive research in this area has led one set of 
investigators to conclude that opioid prescribing practices are idiosyn-
cratic and based largely on providers’ personal beliefs regarding their 
appropriateness (24). It appears to be reasonable to suspect that these 
beliefs may cluster according to specialty due, in part, to the varying 
patient populations served by each. 
In the present study, we examined the relationship between phys-
icians’ primary specialties and their opioid prescribing practices among 
patients with CNCP. Given the preponderant findings of the scant 
and conflicting evidence presented above, we expected to find that 
nonspecialists – eg, GPs – would be more likely than specialists to 
prescribe opioid analgesics to this population. 
METHoDS
Data 
Adults eligible for the Medicaid program in North Carolina (USA) 
include individuals whose incomes are below a defined threshold and 
who also receive cash assistance programs, are blind or disabled, or 
satisfy other need-based criteria (25). North Carolina Medicaid claims 
data for the 12-month period from October 1, 2009 to September 30, 
2010 were examined. The dataset was limited to adults <65 years of 
age because many of the claims for those ≥65 years of age may have 
been filed with the Medicare program and their Medicaid records 
were, thus, unlikely to provide a complete history of their diagnoses 
and related prescriptions. The dataset comprised 1.28 million individ-
uals 18 to 64 years of age in all types of Medicaid program categories 
including income-based and disability-based categories. In the total 
population, 30.5% were men. With regard to race/ethnicity, 47.4% 
were white, 36.6% black, 8.5% Hispanic and 7.4% other; 43.5% were 
18 to 30 years of age, 23.4% were 31 to 40 years of age, 15.9% were 
41 to 50 years of age, and 17.3% were 51 to 64 years of age.
Study data were obtained from the Cecil G Sheps Center for 
Health Services Research of the University of North Carolina (Chapel 
Hill, North Carolina, USA), which in turn received them from the 
Division of Medical Assistance of the North Carolina Department of 
Health and Human Services. The present study was approved by the 
University of North Carolina Institutional Review Board for the 
Protection of Human Subjects.
Measures
Medicaid patients were identified as having CNCP if they had an 
International Classification of Diseases – Ninth Revision diagnosis code at 
any point during the 12-month study period for: chronic pain syn-
drome, headaches (migraine, tension or chronic), back pain, neck 
pain, spinal cord injury, arthritic diseases (including lupus and fibro-
myalgia), sickle cell anemia and burns. Patients were excluded from 
analysis if they had both a cancer and a chronic pain diagnosis.
Opioid analgesics were defined as a prescription for a drug in thera-
peutic class code 40, based on the 1995 National Drug Code directory 
of therapeutic drug classes (26). For the purpose of the present study, 
CNCP patients were only specified as receiving an opioid analgesic if 
they filled the prescription either on the same day or the day following 
the date of physician diagnosis in their medical record. This strategy 
was used to increase the likelihood that the opioid prescription pre-
scribed would be related to the diagnosis. 
Specialties that were believed to be likely to prescribe a majority of 
opioids were examined. Physicians reported their specialties to Medicaid, 
which were subsequently categorized as: ear, nose and throat (ENT); 
dentists; GP/FMs; internal medicine; emergency medicine; orthopedics; 
obstetrics and gynecology (OB/GYN); or other. No specialties were 
excluded; any physicians who did not endorse any of these specialties 
were included in the ‘other’ category. Physicians had the opportunity to 
specify up to three different specialties in their Medicaid provider files, 
although, in practice, <5% of the providers identified more than one of 
the specialties listed. The following rules were used for classifying phys-
icians according to specialty. Physicians were considered to be ENTs, 
dentists, emergency medicine, orthopedics or OB/GYNs if they included 
the specialty in any of the three specialties they specified. Physicians 
were considered to be internists or GPs if they indicated only that spe-
cialty code because medicine subspecialties also have internal medicine 
board certification; thus, those practicing as primary care physicians 
could also be included. For example, a physician categorized as both an 
internist and a cardiologist was included in the ‘other’ category, not the 
internal medicine category. 
Statistical analysis
First, the dataset was examined to determine the potential impact of 
missing data related to provider specialty on the study results. As will 
be observed in the following section, it was concluded that any bias 
introduced by these missing data was likely to be modest and, thus, 
missing data were not considered further.
χ2 statistics were used to examine bivariate differences in prescrib-
ing practices according to specialty. For multivariable analyses, 
maximum-likelihood logistic regression models were used to examine 
the effect of specialty on prescribing practices, controlling for patients’ 
demographic characteristics and specific diagnoses. The SEs for 
within-person similarities across multiple prescriptions (eg, an individ-
ual is likely to receive care from the same specialist) were adjusted 
using a sandwich variance estimator. SEs were calculated using the 
Huber-White robust variance method (27), after subtracting the num-
ber of covariates from the number of observations. Sandwich variance 
estimators, which are used with generalized estimating equations, 
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provide reliable estimates of covariance matrices even in the absence 
of parametric models (28). All analyses were performed using Stata 
12.0 (Stata Corp, USA). 
RESuLTS
Sample description
Data examined for the 12-month period beginning in July 2009 
included 1.28 million patients. Of these, 81,459 (6.4%) had a diagno-
sis code for CNCP associated with visits from July 2009 through June 
2010, and 215,463 (16.9%) of the 1.28 million had filled a prescrip-
tion for an opioid analgesic at least once during the year. Collectively, 
51,793 (4.1%) of all Medicaid patients between 18 and 64 years of age 
had received both a CNCP diagnosis and at least one prescription for 
an analgesic, either on the same day of or subsequent to the day their 
diagnosis was recorded. 
As indicated in Table 1, among patients with CNCP diagnoses, the 
majority were female (69.7%), white (60.2%) and were approximately 
evenly distributed across the age groupings specified. Almost 
two-thirds (63.6%) had filled at least one opioid prescription during 
the year. There were more white patients in the group that filled an 
opioid prescription (64.0%) than in the group that did not (53.5%). 
Although age was evenly distributed among patients who filled at least 
one opioid prescription, those who did not fill one were more likely to 
be older. Table 1, which also includes information about the distribu-
tion of key clusters of diagnoses related to chronic pain, reveals that 
patients with chronic pain syndrome and back pain, relative to the 
other pain-related diagnoses examined, were particularly likely to 
receive a prescription for an opioid.
Study findings
All analyses of prescribing according to specialty are based on the 
73,487 (90.2%) individuals with CNCP who filled at least one pre-
scription of any type, regardless of whether it was an analgesic, on 
the day of or following the visit in which they received a CNCP 
diagnosis code. Of all prescriptions filled by individuals with CNCP, 
12.5% were for opioids. Table 2 presents the distribution of 
TAble 1
Characteristics of Medicaid patients, 18 to 64 years of age, with a diagnosis of chronic noncancer pain, according to filled 
opioid prescription
Characteristic Any opioid prescription filled (n=51,793) No opioid prescription filled (n=29,666) Total (n=81,459)
Total 63.58 36.42
Sex
   Male 29.40 32.02 30.35
   Female 70.60 67.98 69.65
Race/ethnicity
   White 63.97 53.53 60.16
   Black 28.60 38.17 32.08
   Hispanic/Latino 1.63 2.36 1.90
   Other 5.81 5.94 5.86
Age, years
   18–30 26.14 24.38 25.50
   31–40 25.41 19.32 23.20
   41–50 24.19 24.13 24.16
   51–64 24.26 32.17 27.14
Diagnosis*
   Chronic pain syndrome 44.44 30.02 39.19
   Headache 7.73 8.18 7.89
   Back pain 54.79 45.71 51.48
   Neck pain 24.89 22.44 24.00
   Spinal cord injury 1.29 3.88 2.23
   Arthritic diseases 2.75 4.67 3.45
   Sickle cell anemia 1.29 1.66 1.42
   Burns 0.15 0.23 0.18
Data presented as %. *The total exceeds 100% because patients may be given multiple pain-related diagnoses
TAble 2
Proportion of all prescriptions and all opioid prescriptions filled for chronic noncancer pain patients 18 to 64 years of age, 
according to specialty for patients with provider specialty data
Provider specialty n (%) of all prescriptions filled (column %)
n (%) of all opioid prescriptions filled 
(column %)
Opioid prescriptions as % of all 
prescriptions filled, according to specialty 
(row %)
ENT 5186 (0.40) 560 (0.36) 10.80
Dentists 28,194 (2.17) 7492 (4.78) 26.57
GP/FM/DO 405,786 (31.16) 35,881 (22.89) 8.84
Internal medicine 262,846 (20.19) 22,188 (14.16) 8.44
Emergency medicine 87,903 (6.75) 19,924 (12.71) 22.67
Orthopedists 28,178 (2.16) 11,768 (7.51) 41.76
OB/GYN 49,686 (3.82) 5032 (3.21) 10.13
Other specialty 434,389 (33.36) 53,877 (34.38) 12.40
Total prescriptions 1,302,168 (100) 156,722 (100) 12.04
DO Doctor of osteopathic medicine; ENT Ear, nose and throat; GP General practitioner; FM Family medicine; OB/GYN Obstetrics and gynecology
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specialties associated with all prescriptions (n=1,302,168), as well as 
all opioid prescriptions (n=156,722), and also presents the propor-
tion of the total number of prescriptions that each type of specialist 
wrote that represented an opioid prescription. Consistent with their 
greater representation in the population of providers, most dispensed 
prescriptions were written by GP/FMs and by internal medicine spe-
cialists. These two specialties also accounted for the majority of opi-
oid prescriptions written. Dentists wrote more than twice the 
percentage of opioid prescriptions (4.8%) as they did of all prescrip-
tions (2.2%); similarly, emergency medicine providers were over-
represented among all opioid prescriptions (12.7%) relative to their 
representation among all prescriptions (6.8%). Prescriptions from 
the approximately one-third of providers whose specialty was not 
represented in one of the categories specified accounted for almost 
one-third of all prescriptions filled. Proportions of opioid prescribing 
relative to all prescriptions differed according to specialty. Of all 
prescriptions written for patients with CNCP, 8.8% and 8.4% were 
written for opioids by GP/FMs and internal medicine physicians, 
respectively. In contrast, 26.6% of all prescriptions written by den-
tists, 22.7% written by emergency medicine physicians and 41.8% 
written by orthopedists were for opioids.
Table 3 presents differential rates of specialists’ prescriptions of 
opioids to patients, disaggregated according to their demographic 
characteristics. For every specialty, a greater percentage of all the pre-
scriptions dispensed to men than women were for opioids. A greater 
proportion of prescriptions dispensed to white individuals were for 
opioids compared with other races. For all specialties, fewer of the 
prescriptions dispensed to older individuals (51 to 64 years of age) 
were for opioids, although this difference was greatest for GPs, intern-
ists and emergency medicine physicians. Orthopedists were the most 
likely of any specialty to have patients who received opioids: 44.0% of 
orthopedists’ prescriptions for men were for opioids, as were 40.1% of 
their prescriptions for women. The relationships among types of 
specialists and chronic pain diagnoses are presented in Table 4. As this 
table reveals, a greater proportion of prescriptions written by GP/FM 
and internal medicine physicians were for opioids when the patient 
had received a diagnosis of a chronic pain syndrome or sickle cell 
anemia. A greater proportion of prescriptions written by emergency 
medicine physicians were for opioids when the patient had a diagnosis 
of sickle cell anemia, but a lower proportion were written by these 
physicians when the patient had a spinal cord injury or burns.
The results of the multivariable analyses, which are presented in 
Table 5, confirm the results of the bivariate analyses presented above. 
In these analyses, demographic and diagnostic covariates were con-
trolled for; the ORs presented compare each specialty with GP/FMs, 
who served as the referent category. All specialties except internal 
medicine had higher odds of prescribing an opioid than GP/FMs. The 
odds were largest among orthopedists (OR 7.1), dentists (OR 3.5) and 
emergency medicine physicians (OR 2.7). When all other variables 
were held constant, patients with a diagnosis of sickle cell anemia were 
most likely (OR 3.2) to be prescribed an opioid than a prescription for 
any other medication.
Missing data concerning physician specialty
Prescriber number is not a required field for prescription claim reim-
bursement in the North Carolina Medicaid program. Of 3,034,168 pre-
scriptions for patients 18 to 64 years of age who were diagnosed with 
CNCP from October 2009 to September 2010, 1,732,427 (57.1%) 
lacked prescriber identification (and, thus, specialty information). 
Because of the initial concern that these data may have biased the 
analysis of the relationships among provider specialty and opioid pre-
scriptions in the sample of patients with CNCP diagnoses, whether the 
presence of providers’ data was related to their patients’ demographic 
characteristics and primary diagnoses was examined (Table 6). In addi-
tion, the relationships between specialty-missing status and both any 
prescriptions (n=3,034,168) and any opioid prescriptions (n=380,036) 
TAble 3
Percent of all prescriptions for chronic noncancer pain patients that were for opioids, according to provider specialty and 
patient demographics
Provider specialty





















ENT 9.4 16.4 11.0 11.3 11.1 7.4 13.7 10.6 11.3 8.1
Dentists 26.0 27.5 27.1 25.1 26.2 27.4 27.4 26.3 26.3 25.0
GP/FM/DO 8.2 10.4 9.3 8.0 7.2 7.7 11.3 11.0 9.3 6.7
Internal medicine 7.8 10.0 9.0 7.6 7.9 7.0 12.0 11.0 8.7 6.5
Emergency medicine 21.9 24.9 23.2 22.1 19.7 18.8 25.2 25.0 21.9 16.9
Orthopedists 40.8 44.0 42.4 39.4 43.2 45.7 40.6 42.5 44.1 39.1
OB/GYN 9.7 21.2 11.0 7.9 9.3 8.4 9.3 10.8 12.3 8.9
Other 11.5 14.9 12.8 11.4 10.0 12.4 12.1 13.9 12.5 11.3
Data presented as %. DO Doctor of osteopathic medicine; ENT Ear, nose and throat; GP General practitioner; FM Family medicine; OB/GYN Obstetrics and gynecology
TAble 4






















ENT 12.2 8.8 9.9 11.9 3.4 15.4 3.3 0.0
Dentists 30.0 26.1 27.9 27.1 16.7 25.7 33.1 38.9
GP/FM/DO 11.1 8.0 8.8 8.7 8.4 8.0 18.4 2.6
Internal medicine 10.6 8.2 8.1 7.6 7.6 7.5 24.3 11.3
Emergency medicine 25.0 21.6 24.6 25.3 10.1 20.5 45.4 11.9
Orthopedists 42.2 44.0 44.7 46.8 33.0 44.2 46.0 54.8
OB/GYN 14.9 9.1 10.4 9.3 7.7 8.9 13.3 4.8
Other 15.0 8.7 14.4 13.6 10.3 10.0 24.7 9.2
Data presented as %. DO Doctor of osteopathic medicine; ENT Ear, nose and throat; GP General practitioner; FM Family medicine; OB/GYN Obstetrics and gynecology
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were examined. Because all comparisons made in this very large dataset 
were statistically significant, a focus was placed on whether any observed 
differences were meaningful. As presented in the table, differences 
according to sex were small (<2%). With regard to race/ethnicity, non-
Hispanic/Latino individuals were less likely than white or black individ-
uals to have any prescriptions that were missing specialty data; these 
differences were attenuated for opioid prescriptions, in which white 
individuals, black individuals and Hispanic/Latino individuals were all 
within two percentage points of one another. However, a clear trajectory 
was apparent across age groups – younger patients were less likely to 
have missing provider specialty data than older patients – although the 
difference in the percent of these data between the youngest and highest 
age groups was greater for all prescriptions (6.0%) than opioid prescrip-
tions (4.6%). Examining the relationship between the presence or 
absence of specialty information and patients’ chronic pain-related 
diagnoses revealed similarly small differences with regard to whether 
data for this variable were missing.
Given the small magnitude of the differences in patients’ demo-
graphic characteristics and chronic pain diagnoses, missing specialty 
data were not imputed. Because it could not be determined whether 
the data were missing at random – ie, it was not possible to be certain 
that missing values could be explained entirely with available data – 
there was a concern that any imputation procedures would risk gener-
ating more bias than that caused by the missing data themselves. 
Multivariate analyses were limited to cases with no missing data 
because the use of a dummy variable for a missing specialty could have 
also generated bias, and there was adequate power to address the 
study’s research questions even when excluding those observations. 
DISCuSSIoN 
When controlling for patients’ age, sex and race/ethnicity, and category 
of chronic pain diagnosis, and when compared with GPs/FMs, we found 
that the following specialists had the highest odds of prescribing any 
opioid to their CNCP patients: orthopedists (by a ratio of 7.1 to 1), 
dentists (3.5 to 1) and emergency medicine physicians (2.7 to 1). This 
finding was contrary to our hypothesis that specialists would be less 
likely than GP/FMs to prescribe opioid medications, although it was 
consistent with findings reported by Victor et al (7). However, we 
observed no difference in the proportions of prescriptions between GP/
FMs and primary care internal medicine physicians, and only very small 
differences between GP/FMs and both ENTs and OB/GYNs. 
The explanation for each of these prescribing patterns is likely to 
differ, and none should be considered to be potentially aberrant in the 
absence of a full consideration of the context and environment in 
which each specialist practices. Orthopedists, dentists and emergency 
medicine specialists may be more likely than GP/FMs to encounter 
patients who present with acute pain that may exacerbate or be con-
current with underlying chronic pain conditions and, thus, to write a 
relatively high proportion of opioid prescriptions. Orthopedists may 
also see CNCP patients on a repeated basis and, thus, may be more 
likely to bear responsibility for multiple and long-term opioid prescrib-
ing, especially if they are ‘fine tuning’ their patients’ medication. 
Internists are more likely to write prescriptions for a variety of medica-
tions than are dentists, who would appear to be more likely to pre-
scribe opioids to the exclusion of other medications because of the 
nature of their patients’ pain complaints.
Our examination of the demographic characteristics of Medicaid 
patients with CNCP who filled prescriptions yielded some surprising 
results. The proportion of women who filled prescriptions for either opi-
oids or, indeed, any medication was similar to the proportion of women in 
the population studied. However, when we disaggregated these data 
according to providers’ specialty and patients’ age ranges, male patients 
received a greater proportion of prescriptions for opioids almost uniformly 
across specialties. This difference was particularly pronounced for ENT 
TAble 5
logistic regression of likelihood of opioid prescriptions 
according to provider specialty* (n=1,302,168)
OR (95% CI) P
Specialties*
   ENT 1.248 (1.073–1.451) 0.004
   Dentists 3.461 (3.313–3.616) <0.001
   Internal medicine 0.965 (0.925–1.008) 0.107
   Emergency medicine 2.715 (2.612–2.822) <0.001
   Orthopedics 7.115 (6.718–7.535) <0.001
   OB/GYN 1.116 (1.047–1.189) <0.001
   Other 1.392 (1.342–1.443) <0.001
Age 0.985 (0.984–0.987) <0.001
Male 1.304 (1.264–1.344) <0.001
Race/ethnicity†
   Black 0.915 (0.887–0.945) <0.001
   Hispanic 0.879 (0.797–0.970) 0.010
   Other 0.918 (0.866–0.973) 0.004
Pain diagnosis
   Chronic pain 1.875 (1.823–1.929) <0.001
   Headache 1.052 (1.001–1.105) 0.045
   Back pain 1.467 (1.426–1.510) <0.001
   Neck pain 1.226 (1.189–1.263) <0.001
   Spinal cord injury 0.934 (0.825–1.057) 0.279
   Arthritic diseases 1.197 (1.109–1.291) <0.001
   Sickle cell anemia 3.163 (2.791–3.585) <0.001
   Burns 0.975 (0.679–1.401) 0.893
Constant 0.096 (0.091–0.103) <0.001
*General practitioners/family medicine specialists constitute the referent for all 
specialties; †White race/ethnicity constitute the referent for all racial/ethnic 
categories. ENT Ear, nose and throat; OB/GYN Obstetrics and gynecology
TAble 6
Percent of prescriptions missing data pertaining to 
physician specialization according to characteristics of 
chronic noncancer pain patients 18 to 64 years of age, for 




All opioid prescriptions 
(n=380,036)
Sex
   Male 57.85 59.85
   Female 56.82 58.26
Race/ethnicity
   White 56.39 58.54
   Black 57.93 58.01
   Hispanic/Latino 52.62 56.64
   Other 61.89 64.62
Age, years
   18–30 53.24 56.28
   31–40 55.95 58.47
   41–50 57.23 58.74
   51–64 59.25 60.77
Diagnosis
   Chronic pain syndrome 58.48 60.00
   Headache 57.61 60.33
   Back pain 57.04 58.86
   Neck pain 55.77 58.03
   Spinal cord injury 55.59 56.10
   Arthritic diseases 55.34 55.43
   Sickle cell anemia 55.57 57.44
   Burns 66.21 59.39
Total 57.09 58.76
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specialists and OB/GYNs. Notably, we also found that ENTs prescribed 
1.8 times as many opioids to men as to women. It is possible that men may 
be more likely to experience chronic pain as a result of injuries associated 
with physical labour, experience pain that they (or their providers) per-
ceive to be more severe or that they are more heavily involved in drug 
diversion. It is also possible that male smokers are receiving more opioids 
because of oral and neck cancers. Future studies should examine the rela-
tionship between the potential for differential pain severity ratings 
according to sex and providers’ opioid prescribing patterns. We also note 
that, controlling for physicians’ specialties and patients’ age, sex and pain 
diagnosis, white individuals were more likely to be prescribed opioids than 
black individuals, Hispanic individuals, and individuals of other races. 
This finding supports the presence of a significant health disparity in opi-
oid prescribing practices, concerning which there is now considerable lit-
erature (29-31).
Prescribing of opioids according to specialty for specific diagnoses 
revealed clear patterns. A greater proportion of the prescriptions writ-
ten by primary care internists and GP/FM physicians for those living 
with chronic pain conditions were for opioids, likely indicating that 
these physicians are providing much of the care for these patients. The 
greater proportion of prescriptions for opioids written by emergency 
medicine and primary care physicians for patients with sickle cell 
anemia likely represents treatment for acute pain crises.
Limitations
We acknowledge several limitations to our study. First, our study tar-
geted Medicaid patients, who are twice as likely as those in the general 
population to receive an opioid prescription, possibly because of their 
elevated risk for severe illness and injury. Indeed, in many states, a dis-
ability diagnosis constitutes a key criterion for eligibility for the pro-
gram (32). The substantial amount of documentation required to 
establish this diagnosis may also attenuate any providers’ concerns that 
their patients’ complaints of chronic pain may be spurious (33). 
Second, to the extent that the time physicians are able to spend with 
Medicaid patients is constrained, they may lack the time to consult 
their state’s prescription monitoring program concerning their 
patients’ history of prescriptions for controlled substances. Third, our 
findings should be generalized only with caution because the context 
in which providers prescribe, and pharmacists fill, prescriptions for 
controlled substances in North Carolina may differ from that of other 
states. For example, there is considerable variation across the states in 
the provisions of, registration with and utilization of their respective 
prescription drug monitoring programs, all of which could affect pre-
scribing practices (34). There is also variation in the states’ Medicaid 
Lock-in Programs, which are designed to prevent ‘doctor shopping’ 
and other fraudulent activity among high-risk patients (35).
We are also aware of the problems caused by missing specialty 
information in our dataset, particularly the potential for bias if these 
data were differentially associated either with physicians’ specialty or 
with their opioid prescriptions. However, our examination of the dif-
ferences indicates few concerns about bias based on the data available. 
Furthermore, our study relied exclusively on a very large database of 
objective administrative records, as opposed to surveys that rely on 
self-reported behaviours, which may be subject to recall and social 
desirability biases and are often based on limited samples with low 
response rates. That said, more than one-third of all opioid prescrip-
tions filled by this sample of individuals who had received a diagnosis 
of chronic pain were written by specialists who identified themselves 
as ‘other’. Nurse practitioners comprised the plurality (17.7%) of pre-
scribers in the ‘other’ category, and their specialization was routinely 
unavailable, followed by anesthesiologists (16.9%) and surgeons 
(13.4%). A more granular analysis of the ‘other’ category did not alter 
the conclusions in the present study; therefore, we did not report these 
results.
CoNCLuSIoNS
In the present study we found, contrary to expectations, that special-
ists – and, in particular, orthopedists – were more likely than general-
ists (GPs/FMs) to write prescriptions for Medicaid CNCP patients. 
That said, we strongly caution against any conclusions to the effect 
that orthopedists – or any other specialists – may be prescribing opi-
oids at an inappropriately high rate because the diagnoses of the types 
of patients seen by each category of specialists, and the context in 
which each practices, vary widely. More needs to be known about each 
specialty’s standards and norms concerning prescribing analgesics, and 
the care of patients with CNCP diagnoses may be improved if these 
are shared across specialties. 
Clinicians are in the unenviable position of weighing their respon-
sibility to provide patient-centred, compassionate care to their 
patients with CNCP against the risk of a variety of harms to their 
patients (36), including abuse, addiction, dependence and overdose 
(16,37,38). In the absence of clear and unequivocal guidelines 
regarding what constitutes best practice in pain management for 
CNCP patients, physicians must continue to be given considerable 
latitude to do what they believe is best for their patients.
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